Anto Biosciences
San FranciscoDrug development has long been hobbled by a quietly devastating problem: the same medicine that works for one patient can prove ineffective – or even toxic – for the next. Increasingly, the suspect is the trillions of microbes living inside us. Anto Biosciences, a Y Combinator Fall 2025 company, believes microbiome drug development can finally […]
